Animal Study
Explore A-Z conditions
Cannabis for Parkinson’s Disease (PD)
Double Blind Human Trial
2
Human Trial
4
Laboratory Study
13
Meta-analysis
55
Total studies
Parkinson’s Disease (PD)
91
Positive
84 studies
93%
Inconclusive
5 studies
5%
Negative
2 studies
2%
Select your state from the drop down and we’ll let you know.
The information in our comprehensive A to Z encyclopedia comes from real scientific studies.
Uncover the detailed results of these studies and find out how effective medical marijuana is for dozens of conditions.
- Amyloid Proteotoxicity Initiates An Inflammatory Response Blocked By Cannabinoids
- Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB 1 R gene expression and reduces dyskinesias in a rat model of Parkinson's disease
- A systematic review of cannabidiol dosing in clinical populations
- A systematic review of minor phytocannabinoids with promising neuroprotective potential
- A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders